Sweet bay

Sweet Bay (Laurus nobilis L.): A Comprehensive Reference

1. Identity and Botanical Description

Nomenclature and Taxonomy

The commodity traded as sweet bay leaf, and true, Roman, or Turkish laurel, is derived from the leaves of Laurus nobilis L. (Family – Lauraceae). Its common names include bay tree (especially in the United Kingdom), bay laurel, sweet bay, true laurel, Grecian laurel, or simply laurel. In the scientific literature, Laurus nobilis L., known as bay, sweet bay, bay laurel, Roman laurel, or daphne, is an evergreen Mediterranean shrub whose leaves have traditionally been used in cuisines and folk medicine due to their beneficial health effects.

The name "daphne" reflects the plant's deep roots in classical mythology. Bay leaf (Laurus nobilis L.) is called dafni in Greek, in reference to the myth about the god Apollo pursuing the nymph Daphne; in response to her pleadings, the gods granted her protection by turning her into a bay tree, and the heartbroken Apollo subsequently symbolized the tree in honor of love-shorn poets.

Taxonomic caution: Because of the similarity in the leaves, several other trees are also variously known as bay — including the West Indian bay tree (Pimenta racemosa), cherry laurel (Prunus laurocerasus), Portugal laurel (Prunus lusitanica), laurel of the southern states (Prunus caroliniana), and the California mountain laurel (Umbellularia californica). However, the leaves of true L. nobilis must not be confused with these other laurels. It is important not to harvest "laurel" without certainty of species identification: bird cherry laurel (Prunus laurocerasus) is similar in appearance but contains toxic glycosides.

Botanical Characteristics

Laurus nobilis is an aromatic evergreen tree or large shrub with green, glabrous (smooth) leaves, belonging to the flowering plant family Lauraceae. The stem can be 1 metre in diameter and the tree can be as high as 20 metres. It is native to the Mediterranean region and is used as bay leaf for seasoning in cooking. The leaves are glabrous, 6–12 cm long and 2–4 cm broad, with an entire (untoothed) margin; on some leaves the margin undulates. Since the bay laurel is dioecious (male and female on separate plants), small, pale yellow-green flowers followed by small, berry-like drupes appear on the female trees; as the one-seeded fruit matures it becomes purplish black.

Geographic Distribution and Cultivation

L. nobilis is a native of the Mediterranean and grows spontaneously in scrubland and woods in Europe and in California. It is widely cultivated in Europe, America, and in Arabian countries from Libya to Morocco. Sweet bay is a medium-sized tree whose aromatic leaves are used as a culinary herb (bay leaf), earning it the distinction of Herb of the Year 2009 by the International Herb Association.

Plant Parts Used and Common Preparations

The primary plant parts used medicinally are the leaves, berries, and bark. Leaves are the most commonly used part, harvested during summer months when their essential oils are most concentrated. The berries, which are dark purple to black in color, are also utilized, particularly in traditional remedies. Bark from older trees may be used in specific formulations, though less frequently than leaves and berries.

Common preparations encountered in traditional and modern use include:

• Dried whole or ground leaves — the most widely traded form, used in cooking and encapsulated as a dietary supplement.
• Leaf infusion and decoction — folk medicine in many countries uses the infusion of the plant in stomachic and carminative remedies, as well as for the treatment of gastric diseases.
• Essential oil (leaf) — obtained by hydrodistillation of fresh or dried leaves; the leaves contain volatile oils that accumulate in the palisade and mesophyll cells and are present at 1–3% on a fresh weight basis.
• Fruit/berry oil (Oleum Lauri) — obtained from the berries by distillation with water; the crude oil is pale yellow and transparent, readily soluble in alcohol and ether. Bay oil or Oil of Bays (Oleum Lauri) is used in liniments for bruising and sprains.
• Hydroalcoholic and ethanolic extracts — prepared for experimental and commercial purposes to concentrate polyphenolic fractions.

2. Traditional and Historical Use

Ancient Greece and Rome

Laurus nobilis figures prominently in classical Greco-Roman culture. In ancient Greece and Rome, bay leaves were used to make crowns for kings, war heroes, and Olympians, and were said to provide protection from disease and evil spirits. Laurel was famously used to crown emperors and great men and was dedicated to the god Apollo and the god of medicine Aesculapius; bay leaf is lightly narcotic and was closely associated with trances and oracles. The priestesses at the Temple of Delphi may have consumed high-dose bay leaf preparations to induce a trance state and divine the will of the gods.

Hippocrates, the father of medicine, and the authors of the Hippocratic Corpus provided more than 1,500 herbal remedies and described physiological actions for 300 plants; approximately 40 percent of these plant uses came from only 44 plants, including bay laurel (Laurus nobilis). The ancient Greek physician is recorded to have prescribed leaves and berries for medicinal purposes: Hippocrates used both the leaves and berries of the bay-tree in medicine.

Laurel garlands became an architectural element as the plant was believed to protect from disease, evil spells, and lightning, and it was also used as a remedy against the plague. A bath with leaves of bay (Laurus nobilis L., Lauraceae) was employed in ancient medicine and described as effective against urinary diseases.

Traditional Medicinal Uses Across Cultures

L. nobilis leaves have traditionally been used in Mediterranean cuisine for seasoning, as well as in folk medicine along with L. nobilis fruits for treating viral infections, cough, rheumatism, impaired digestion, diarrhea, and other health conditions.

Laurus nobilis has been used for its astringent, carminative, diaphoretic, digestive, diuretic, emetic, and stomachic properties. Ancient Greeks and Romans used laurel to treat ailments such as digestive issues, respiratory conditions, and as a general tonic; it was also employed in baths to relieve muscle pain and as a purifying agent. In medieval Europe, it was valued for its antiseptic properties and used in treating wounds and infections.

Laurus nobilis L. is commonly used in folk medicine in the form of infusion or decoction to treat gastrointestinal diseases and flatulence as a carminative, antiseptic, and anti-inflammatory agent. Culinary uses of the bay leaf have existed since the ancient Greeks. Today, bay leaves are added to foods to improve digestion (such as lentils), prepared as a tea to help fight colds and fevers, and used externally to relieve arthritic pain and swelling.

3. Key Constituents and Active Compounds

Volatile Essential Oil

The chemical composition of the essential oil depends on environmental conditions, location, and season during which the plants are collected, drying methods, extraction, and analytical conditions. Nevertheless, consistent patterns emerge across studies. The major oil components identified across geographic populations include 1,8-cineol (43.52–31.31%), methyl-eugenol (14.96–4.07%), α-terpinyl acetate (13.00–8.51%), linalool (11.72–1.08%), sabinene (10.57–4.85%), α-pinene (7.41–3.61%), eugenol (4.12–1.97%), and terpinen-4-ol (2.33–1.25%).

In a well-characterized study of Southern Italian material, the chemical composition of the essential oil from leaves of L. nobilis was studied by GC and GC-MS; 55 compounds were identified, accounting for 91.6% of the total essential oil, with 1,8-cineole (31.9%), sabinene (12.2%), and linalool (10.2%) as the main components.

The expectorant, bronchodilatory, and antibacterial qualities of 1,8-cineole, a predominant constituent in the majority of bay leaf chemotypes, have been thoroughly investigated. Using 1,8-cineole as the predominant biomolecule found in the L. nobilis essential oil, molecular docking studies have been performed; these simulations propose that the recorded biological activities emanate from this compound's high ability to form strong and effective hydrophobic interactions within the binding sites of crystallographic protein targets.

Polyphenolic Compounds

Many biological activities of L. nobilis can be attributed to phenolic compounds present in leaves, which include flavonoids, phenolic acids, tannins (proanthocyanidins), and lignans. Some of the other constituents found in L. nobilis leaves are alkaloids, norisoprenoids, sugars, polysaccharides, organic acids, and tocopherols.

Laurus nobilis leaf infusion contains significant antioxidant compounds, primarily flavonoid glycosides; isolation work has identified 13 compounds, including a novel kaempferol C-glycoside, enhancing understanding of its phytochemical profile. Phenolic compounds play key roles in reducing oxidative stress and modulating enzymatic activities, relevant to metabolic and neurodegenerative disorders. Specific phenolics identified by LC-MS/MS analysis include luteolin, ellagic acid, and myricetin. Luteolin is a flavone with antioxidant, anti-inflammatory, anticancer, antiallergic, and neuroprotective properties and is present in many plant species, particularly in leaves, barks, and herbs. Ellagic acid is a polyphenol with antioxidant, anti-inflammatory, antimutagenic, and antitumor activities.

Terpenoids

L. nobilis is rich in terpenoids, with more than 200 entities identified in reported studies; terpenoids from L. nobilis have shown a wide range of pharmacological activities, including anti-inflammatory, antidiabetic, antifungal, antibacterial, immunomodulatory, anticonvulsant, antioxidant, and cytotoxic activities.

Other Constituents

The main chemical compounds that show bioactive properties in L. nobilis are terpenoids, phenolics, and fatty acids. The oil from berries was once used to keep moths away, owing to its lauric acid content, which gives it insecticidal properties.

4. Mechanisms of Action

Antimicrobial Mechanisms

L. nobilis demonstrates broad-spectrum antimicrobial activity against bacteria, fungi, protozoa, and viruses, largely attributed to its essential oil constituents. Monoterpenes such as 1,8-cineole, linalool, α-terpinyl acetate, α-pinene, and β-pinene exert antimicrobial effects primarily through disruption of microbial cell membranes, increased permeability, and inhibition of key enzymatic pathways.

Anti-Inflammatory Mechanisms

Studies show that essential oils from L. nobilis have strong anti-inflammatory properties; these effects could be attributed to the presence of various bioactive molecules such as eucalyptol (1,8-cineole), α-terpinen-4-ol, camphor, α-terpinyl acetate, linalool, limonene, α-pinene, and camphene. Research has highlighted the anti-inflammatory effects of laurel essential oil via interference with the enzyme soluble epoxide hydrolase (sEH), a key enzyme in the arachidonic acid cascade.

Antidiabetic Mechanisms

The bioactive components in bay leaves have been shown to have effects on insulin sensitivity, glucose uptake, antioxidant status, inflammatory response, and glucose emptying. An in vitro study showed that L. nobilis ethanolic extract improves insulin sensitivity by increasing insulin receptor substrate expression and reduces considerably the intracellular oxidative stress induced by chronic hyperglycemia.

Antioxidant Mechanisms

The mechanisms of action of terpenoids from L. nobilis include the imbalance of the ionic permeability of the cell membrane (anti-inflammatory and antimicrobial activities) and modulation of the effects of gamma-aminobutyric acid (GABA)-ergic neurotransmission (anticonvulsant). Polyphenolic fractions act through multiple radical-scavenging pathways; phenolic-rich fractions from L. nobilis exert significant cytoprotective and antioxidant responses in hydrogen peroxide- and amyloid β-fragment-oxidized cell systems.

5. Scientific Evidence by Area of Use

5.1 Blood Glucose and Type 2 Diabetes

Human/Clinical Evidence

The most significant piece of clinical evidence comes from a small randomized controlled trial published in 2009. Bay leaves (Laurus nobilis) have been shown to improve insulin function in vitro. A study to determine whether bay leaves may be important in the prevention and/or alleviation of type 2 diabetes assigned forty people with type 2 diabetes to four groups given capsules containing 1, 2, or 3 g of ground bay leaves per day for 30 days, or a placebo followed by a 10-day washout period. All three dosage levels of bay leaves reduced serum glucose, with significant decreases ranging from 21 to 26% after 30 days; total cholesterol decreased 20 to 24%, with larger decreases in LDL cholesterol of 32 to 40%.

HDL cholesterol increased 29% and 20% in the groups receiving 1 and 2 g of bay leaves, respectively. Triglycerides also decreased 34% and 25% in groups consuming 1 and 2 g of bay leaves, respectively, after 30 days.

A related study administered the same treatment to type I diabetic patients and reported similar beneficial effects. Additionally, cookies containing bay leaf powder (not less than 6% w/w) exhibited significant benefit on postprandial glucose level in healthy human subjects.

Evidence Strength: The randomized, placebo-controlled trial (n=40, 30 days) used capsules containing 1–3 g/day of ground Laurus nobilis and is an encouraging but limited result in terms of size and duration, making it difficult to extrapolate to long-term, daily dietary use of the spice. Comparative reviews highlight the potential of phenolic compounds and flavonoids for antioxidant and possible antidiabetic effects, but most of this data is obtained in animal and cell models; large, long-term, and standardized studies in humans are needed for clinical practice.

5.2 Antimicrobial and Antifungal Activity

In Vitro Evidence

In a study of L. nobilis essential oil from Southern Italy, with 1,8-cineole (31.9%), sabinene (12.2%), and linalool (10.2%) as the main components, antimicrobial and antifungal activities of the EO and 1,8-cineole were determined in vitro. The antibacterial activity was tested on five bacterial strains belonging to both Gram-positive and Gram-negative bacteria — namely Staphylococcus aureus, Bacillus cereus (two strains), Escherichia coli, and Pseudomonas aeruginosa.

In a Moroccan study, the main volatile compounds detected in L. nobilis were eucalyptol (40.85%), α-terpinyl acetate (12.64%), and methyl eugenol (8.72%). Both the essential oil significantly inhibited all the microorganisms tested; the EO from L. nobilis had the highest activity, with minimal inhibitory concentrations (MICs) ranging from 1.39 to 22.2 mg/mL for bacteria and between 2.77 and 5.55 mg/mL for yeasts.

Regarding antifungal activity, fungal strains including Aspergillus niger, A. versicolor, Penicillium citrinum, and P. expansum were sensitive to both the L. nobilis EO and 1,8-cineole; P. expansum exhibited the most sensitivity.

Evidence Strength: All currently available antimicrobial evidence is in vitro. Pharmacological studies further suggest antimicrobial, antioxidant, anti-inflammatory, and neuroprotective activities, though most evidence remains derived from in vitro and preclinical models. Critical gaps in the literature include limited chemotype standardization, scarcity of clinical validation, and insufficient integration of ecological and genetic data.

5.3 Anti-Inflammatory and Analgesic Activity

Preclinical Evidence

The great number of phytochemicals in L. nobilis EOs exerts physiological effects and therapeutic potential, including anticonvulsant, in vitro antibacterial, antifungal, antidiabetic, analgesic, and anti-inflammatory activities, among others. Both in vivo and in vitro tests show that the EOs obtained from the leaves of L. nobilis have strong anti-inflammatory properties.

Evidence Strength: Anti-inflammatory and analgesic evidence is predominantly preclinical (animal and in vitro), with no controlled human clinical trials identified in the published literature at this time.

5.4 Neuroprotection and Cognitive Function

In Vitro Evidence

Alzheimer's disease (AD) is believed to be caused in part by oxidative stress, which leads to the generation of amyloid β-protein (Aβ) and neuronal apoptosis; inhibiting this cycle is an attractive therapeutic strategy, and herbal drugs with antiamyloidogenic and antioxidant properties are considered a valid approach. Phenolic-rich fractions of Laurus nobilis, which exhibited an absence of toxic effects toward human neuronal cell lines, exerted significant cytoprotective and antioxidant responses in hydrogen peroxide- and Aβ(25-35)-fragment-oxidized cell systems; the potential antiamyloidogenic efficacy of Laurus nobilis leaf polar extracts in the Aβ system has been proposed.

The influence of L. nobilis EO on the expression of adenylate cyclase 1 (ADCY1) in SH-SY5Y neuroblastoma cells has been investigated, suggesting possible essential oil effects on the Central Nervous System.

Studies focusing on L. nobilis phenolic content and its anticholinergic properties find relevance in metabolic and neurodegenerative disorders, as phenolic compounds play key roles in reducing oxidative stress and modulating enzymatic activities.

Evidence Strength: Neuroprotective evidence is entirely preclinical, derived from cell-culture experiments. No human clinical trials have been conducted in this area.

5.5 Anticancer Activity

In Vitro Evidence

A study exploring the anticancer, antioxidant, and phytochemical activities of Laurus nobilis L. ethanolic leaf extract demonstrated selective cytotoxicity against four human cancer cell lines, showing strong cytotoxic effect against ovarian (ES2), head and neck (SAS), and colorectal (HT-29) cancer cells, with IC₅₀ values ranging from 3.8 ± 0.3 to 4.4 ± 0.6 µg/mL. The extract exhibited only moderate inhibition of the MDA-MB-231 breast cancer cell line (IC₅₀ = 18.5 ± 0.8 µg/mL), possibly reflecting intrinsic differences in cell line sensitivity. The extract showed low toxicity toward normal human fibroblasts (HDF), with an IC₅₀ value exceeding 100 µg/mL, indicating a favorable selectivity profile.

The anti-proliferative properties of several spices with known antimicrobial activity have been examined, including L. nobilis; results showed that ethanolic crude extracts of L. nobilis had a notable antiproliferative effect on an adenocarcinoma of the breast cell line (MCF7), with an IC₅₀ value of 24.49 μg/mL.

Evidence Strength: Anticancer evidence is exclusively in vitro. No clinical trials in humans have been conducted. These results are preliminary and must not be interpreted as evidence of clinical anticancer efficacy.

5.6 Lipid Profile and Cardiovascular Risk Markers

The 2009 clinical trial described in section 5.1 also captured cardiovascular-relevant outcomes: bay leaves have shown insulin-enhancing activity in vitro and enhance glucose metabolism and the overall condition of individuals with diabetes not only by hypoglycemic effects but also by improving lipid metabolism, antioxidant status, and capillary function; bay leaves reduced serum glucose, total cholesterol, LDL cholesterol and triglycerides, and increased HDL-cholesterol levels in people with type 2 diabetes.

Evidence Strength: As with the glycemic evidence, these findings are limited to one small short-duration RCT (n=40) and have not been independently replicated in large controlled trials.

5.7 Gastrointestinal Applications

Laurus nobilis has historically been used for its carminative, digestive, and stomachic properties. Infusions of the leaf are used across Mediterranean folk medicine for flatulence, eructation, and gastric complaints. Folk medicine in many countries uses the infusion of the plant in stomachic and carminative remedies, as well as for the treatment of gastric diseases. No controlled human clinical trials specifically examining gastrointestinal endpoints have been identified in the published literature.

5.8 Anticonvulsant Activity

Scientific studies highlight anticonvulsant activity of L. nobilis leaf extracts and essential oils, among numerous other reported activities. This evidence is, at present, derived solely from animal experiments and in vitro assays; no human clinical trials have been identified for this endpoint.

6. Body Systems and Health Areas Associated with Sweet Bay

• Metabolic/Endocrine System: Blood glucose regulation, insulin sensitization, lipid profile modulation (supported by one small human RCT and multiple animal studies).
• Immune/Antimicrobial: Broad-spectrum antibacterial and antifungal activity, anti-inflammatory effects (in vitro and animal evidence).
• Nervous System: Anticonvulsant, neuroprotective, anticholinesterase activity (preclinical evidence only).
• Gastrointestinal System: Carminative, stomachic, antiulcerogenic (traditional use; limited experimental data).
• Respiratory System: Expectorant and bronchodilatory properties attributed to 1,8-cineole; used in traditional medicine for coughs and respiratory ailments.
• Musculoskeletal System: External application for rheumatic pain and bruising via bay berry oil (Oleum Lauri).
• Integumentary System/Dermatology: Historical use for rashes; essential oil preparations used in topical liniments.
• Oncology (experimental): In vitro antiproliferative effects against multiple cancer cell lines.

7. Dosage Forms and Dosages Reported in Studies

The following dosages reflect only those explicitly reported in identified peer-reviewed sources; they are not prescriptive recommendations:

• Ground bay leaf capsules (oral, human RCT): Forty people with type 2 diabetes were divided into 4 groups and given capsules containing 1, 2, or 3 g of ground bay leaves per day for 30 days, or a placebo followed by a 10-day washout period.
• Bay leaf powder in food (human study): Cookies containing bay leaf powder (not less than 6% w/w) exhibited significant benefit on postprandial glucose level in healthy human subjects.
• Leaf extract (animal study, rat): A dose of 200 mg/kg of bay extract was administered orally using an intragastric tube every day for 28 days to streptozotocin-induced diabetic rats.
• Leaf infusion (observational): Flavonoid content in an infusion of bay leaves reaches approximately 5.0 mg per 200 mL serving.
• Essential oil (in vitro): The EO from L. nobilis demonstrated MICs ranging from 1.39 to 22.2 mg/mL for bacteria and between 2.77 and 5.55 mg/mL for yeasts.

8. Safety Considerations and Known Interactions

Allergic Contact Dermatitis

Some cases of allergic contact dermatitis to bay fruit oil have been reported. This condition is rather rare and usually affects aromatherapists or traditional medicine users who frequently expose themselves to L. nobilis. The Information Network of Departments of Dermatology (IVDK) indicates that around 1% of patients with patch-tested dermatitis show a positive reaction to laurel leaf extract.

Non-occupational contact allergy to Laurus nobilis (laurel) oil is considered rare; one documented case of allergic contact dermatitis occurred after a massage with a mixture of olive oil and L. nobilis oil, with patch testing showing strong (+++) reactions to laurel oil.

Research into the chemical identity of the sensitizing agents has established that two methods using methylenelactone dimethylamino adducts were used to remove selectively alpha-methylene gamma-butyrolactones from Laurus nobilis L. extracts; isolated lactones were identified and "treated" extracts recovered. When guinea-pig groups were sensitized to crude extracts and "treated" extracts, only the group sensitized to crude extracts showed strong skin reactions to the crude extracts and to the lactones; treated extracts were shown to be anallergic. This indicates that sesquiterpene lactones (alpha-methylene gamma-butyrolactones) are the primary contact allergens in L. nobilis.

Physical Hazards from Whole Leaves

Whole, rigid dried bay leaves used in cooking present a recognized, if uncommon, physical hazard if inadvertently swallowed. Published case reports in the medical literature have documented duodenal obstruction, perforation of Meckel's diverticulum, upper gastrointestinal hemorrhage, and airway impaction from whole dried leaves. Ground bay leaves, however, can be ingested safely and are often used in soups and stocks.

Drug Interactions and Special Populations

Herbal reference books explicitly warn that when combining bay leaf with insulin or oral hypoglycemic medications, glucose levels should be monitored more frequently; caution is also advised when preparing for surgery and in conditions where fluctuations in blood sugar are undesirable.

Concentrated essential oils can be irritating and toxic when ingested; the risk is especially high for children and pets. Taking any essential oils internally for diabetes or in general is not evidence-based and carries real risks, as noted in clinical toxicology guidelines.

Nomenclatural Confusion as a Safety Issue

A critical botanical confusion exists: the bird cherry laurel (Prunus laurocerasus) is similar in appearance to L. nobilis but contains toxic cyanogenic glycosides; only Laurus nobilis — purchased and properly labeled — is safe for culinary and medicinal use.

Evidence Gaps

Pharmacological studies suggest antimicrobial, antioxidant, anti-inflammatory, and neuroprotective activities, though most evidence remains derived from in vitro and preclinical models. Critical gaps in the literature include limited chemotype standardization, scarcity of clinical validation, and insufficient integration of ecological and genetic data. The totality of clinical evidence in humans is currently limited to a single small, short-duration RCT on glycemic and lipid parameters, with all other reported bioactivities based on cell-culture or animal research.

References

• Dobroslavić E. et al. (2022). Isolation of Laurus nobilis Leaf Polyphenols: A Review on Current Techniques and Future Perspectives. PMC.
• Paparella A. et al. (2022). A Review of the Botany, Volatile Composition, Biochemical and Molecular Aspects, and Traditional Uses of Laurus nobilis. Plants (MDPI). PMC.
• Caputo L. et al. (2017). Laurus nobilis: Composition of Essential Oil and Its Biological Activities. Molecules. PMC.
• Anzano A. et al. (2024). Essential Oils of Laurus nobilis L.: From Chemical Analysis to In Silico Investigation of Anti-Inflammatory Activity by Soluble Epoxide Hydrolase (sEH) Inhibition. PMC.
• Hammi K.M. et al. (2022). Chemical Composition, Antioxidant, Anti-Diabetic, Anti-Acetylcholinesterase, Anti-Inflammatory, and Antimicrobial Properties of Arbutus unedo L. and Laurus nobilis L. Essential Oils. PMC.
• Qaoud M.T. et al. (2024). Biological, phytochemical and molecular docking characteristics of Laurus nobilis L. fresh leaves essential oil from Palestine. BMC Complementary Medicine and Therapies. PMC.
• Kocak M.Z. et al. (2025). Therapeutic potential of Laurus nobilis extract by experimental and computational approaches: phenolic content and bioactivities for antioxidant, antidiabetic, and anticholinergic properties. PMC.
• Khan A. et al. (2009). Bay leaves improve glucose and lipid profile of people with type 2 diabetes. Journal of Clinical Biochemistry and Nutrition. PubMed.
• Alsamarraie A.M.A. et al. (2021). Biomedical effects of Laurus nobilis L. leaf extract on vital organs in streptozotocin-induced diabetic rats: Experimental research. PMC.
• Domingues F. & Duarte A.P. (2023). Laurus nobilis Leaves and Fruits: A Review of Metabolite Composition and Interest in Human Health. Applied Sciences (MDPI).
• Al-Sayed E. et al. (2025). The Therapeutic Potential of Laurus nobilis L. Leaves Ethanolic Extract in Cancer Therapy. PMC.
• Pacifico S. et al. (2014). Neuroprotective potential of Laurus nobilis antioxidant polyphenol-enriched leaf extracts. Chemical Research in Toxicology. PubMed.
• Nafis A. et al. (2020). A Comparative Study of the in Vitro Antimicrobial and Synergistic Effect of Essential Oils from Laurus nobilis L. and Prunus armeniaca L. from Morocco. PMC.
• Nagata N. et al. (2024). Effects of Laurus nobilis Leaf Extract (LAURESH®) on Oral and Gut Microbiota Diversity in Mice. PMC.
• Adişen E. & Önder M. (2007). Allergic contact dermatitis from Laurus nobilis oil induced by massage. Contact Dermatitis. PubMed.
• Cheminat A. et al. (1984). Allergic contact dermatitis to laurel (Laurus nobilis L.): isolation and identification of haptens. Archives of Dermatological Research. PubMed.
• Nayak B.S. et al. (2006). Evaluation of wound healing activity of Allamanda cathartica L. and Laurus nobilis L. extracts on rats. PMC.
• Abi-Khattar A.M. et al. (2026). Lebanese bay leaves (Laurus nobilis): A unique chemotypic and pharmacological profile with culinary and medicinal potential. Journal of Food Composition and Analysis. ScienceDirect.
• ScienceDirect Topic Overview: Laurus nobilis.
• UW-Madison Division of Extension Horticulture. Sweet Bay, Laurus nobilis.
• Wikipedia: Laurus nobilis.
• Herbal Academy. The Father of Medicine: Was Hippocrates an Herbalist?
• Herb Society of America. Bay Laurel, Laurus nobilis.
• Khaled S. et al. (2021). laurus nobilis leaves extract protects against high fat diet-induced type 2 diabetes in rats. Journal of Pharmacognosy and Phytotherapy.
• Jabłońska-Trypuć A. et al. (2023). Plant-Based Antioxidants for Prevention and Treatment of Neurodegenerative Diseases: Phytotherapeutic Potential of Laurus nobilis, Aronia melanocarpa, and Celastrol. PubMed.